Patents
Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
07/2000
07/20/2000WO2000041985A1 Process and products of purification of anhydrosugar alcohols
07/20/2000WO2000015593A3 Process for making aromatic aldehydes
07/20/2000WO2000000514A9 Synthetic spiroketal pyranes as potent anti-cancer agents
07/20/2000WO1999064048A9 Inhibitors of hiv reverse transcriptase
07/20/2000CA2629496A1 Process and products of purification of anhydrosugar alcohols
07/20/2000CA2629484A1 Process and products of purification of anhydrosugar alcohols
07/20/2000CA2360383A1 Artemisinin analogs having antimalarial, antiproliferative, and antitumor activities and chemoselective methods of making the same
07/20/2000CA2359557A1 Process and products of purification of anhydrosugar alcohols
07/20/2000CA2355326A1 Photopolymerizable vinyl ether based monomeric formulations and polymerizable compositions which may include certain novel spiroorthocarbonates
07/19/2000EP1019453A1 Aromatic-substituted xanthene dyes
07/19/2000EP1019398A1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives useful for inhibition of farnesyl protein transferase
07/19/2000EP1019389A2 Epothilone derivatives
07/19/2000EP1019042A1 Anti-first-pass effect compounds
07/19/2000CN1260801A Novel glycosylated ginkgolide derivatives, their applicated as medicines and pharmaceutical compositions
07/19/2000CN1260789A Heterocyclic compounds, method for preparing and medicine compositions containing same
07/19/2000CN1054606C Process for preparing anti-virus chemical compound-Babaosu
07/18/2000US6090955 Liposome-encapsulated taxol, its preparation and its use
07/18/2000US6090845 Hypotensive agent; vision defects
07/18/2000US6090610 Macrolide compound 0406
07/18/2000CA2113656C Isolation and structure of spongistatin 1
07/06/2000WO2000039276A2 Microbial transformation method for the preparation of an epothilone
07/06/2000WO2000038674A1 COMPOUNDS WHICH AFFECT mRNA STABILITY AND USES THEREFOR
07/06/2000CA2356622A1 Compounds which affect mrna stability and uses therefor
07/06/2000CA2356360A1 Microbial transformation method for the preparation of an epothilone
07/05/2000EP1015469A2 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues
07/05/2000EP1015446A1 (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents
07/05/2000EP1015443A1 Thromboxane ligands
07/05/2000EP1015440A1 Polyglycidyl spirocompounds and their use in epoxy resins
07/05/2000EP1014969A1 Plant proanthocyanidin extract effective at inhibiting adherence of bacteria with p-type fimbriae to surfaces
07/04/2000US6084109 Gas phase oxidation and dehydration of a 1,2,4,5-tetraalkyl-benzene under normal pressure and heating using a durable, thermoconductive catalyst system of a catalyst support of tungsten and/or silicon carbide
07/04/2000US6083982 Stimulating sodium excretion in the urine of a mammal comprising administering to the mammal a alkoxyalkyl or hydroxy alkyl substituted phenolic compound
06/2000
06/29/2000WO2000037473A1 Epothilone derivatives and their use as antitumor agents
06/29/2000WO2000037437A1 Novel herbicides
06/28/2000CN1258301A Antiviral protease inhibitors
06/28/2000CN1258289A Substd. 2-benzoyl-cyclohexane-1,3-diones
06/27/2000US6080741 Arglabin compounds and therapeutic uses thereof
06/27/2000US6080240 Method for recovering sublimable material
06/22/2000WO2000035900A1 Optical molecular sensors for cytochrome p450 activity
06/22/2000WO2000035898A1 HYDRONAPHTHO[2,3-c]FURAN DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
06/22/2000WO2000035895A1 Process for production of an oxetane
06/22/2000WO2000035865A2 Tubulin-binding agents
06/22/2000CA2354516A1 Hydronaphtho[2,3-c]furan derivatives and process for the preparation thereof
06/22/2000CA2352631A1 Optical molecular sensors for cytochrome p450 activity
06/21/2000CN1257507A Novel triptolide derivatives useful in the treatment of autoimmune diseases
06/21/2000CN1257496A Block oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl groups as stabilizer for organic materials
06/21/2000CN1257495A Block oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials
06/21/2000CN1257494A Block oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials
06/21/2000CN1257493A Block oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl groups a stabilizers for organic materials
06/21/2000CN1257489A Substituted benzopyran derivatives for the treatment of inflammation
06/21/2000CN1053662C New tricyclic amide compounds, processes for their preparation and the pharmaceutical compositions containing same
06/21/2000CN1053556C Compositions containing 13-alkyl-23-imino derivative of LL-28249 compounds and their use
06/20/2000US6077864 Cyclic sulfone derivatives
06/20/2000US6077850 Useful for treating cyclooxygenase-2 mediated disorders, such as inflammation and inflammation-related disorders
06/20/2000US6077844 Pyrimidine derivatives and methods of making and using these derivatives
06/15/2000WO2000034221A1 Nitric acid removal from oxidation products
06/14/2000EP1007056A1 Method for the treatment of cystic fibrosis
06/14/2000EP1007034A1 Compositions containing bergamottin for increasing the oral bioavailability of pharmaceutical agents
06/14/2000EP1007031A1 4-cyano-4-deformylsordarin derivatives
06/14/2000EP0710223B1 Synthesis of taxol and its derivatives
06/13/2000US6075155 Photopolymerizable monomers; solvent-free
06/13/2000US6075140 Pentacyclic compound
06/13/2000US6075018 Tranquilizers
06/13/2000US6074855 Fermenting a culture of a fungus selected from sporotrichum or phanerochaete species and isolating antibiotic compound; bactericides against helicobacter; antiulcer agents
06/08/2000WO2000032604A1 Macrolide compounds and method for evaluating immunosuppressants
06/08/2000WO2000032603A1 4'-substituted-4',5'-dihydropsoralens and therapeutical uses thereof
06/08/2000WO2000032183A1 Topiramate and related derivatives for treating schizophrenia
06/08/2000CA2352258A1 4'-substituted-4',5'-dihydropsoralens and therapeutical uses thereof
06/08/2000CA2319646A1 Topiramate and related derivatives for treating schizophrenia
06/07/2000EP1005493A1 Antiviral protease inhibitors
06/07/2000EP1005465A2 New epothilone derivatives, method for producing same and their pharmaceutical use
06/07/2000EP1005464A1 Photochromic naphthopyrans
06/07/2000EP1005356A1 Novel antibacterial agents
06/07/2000EP1005338A1 Substituted aurone derivatives
06/06/2000US6071946 Tricyclic urea compounds
06/06/2000US6071938 Benzopyrans
06/06/2000US6071853 Crystalline fluoran compound
06/02/2000WO2000031247A2 Recombinant methods and materials for producing epothilone and epothilone derivatives
06/02/2000WO2000031081A2 Amino- and mercurio-substituted 4',5'-dihydropsoralens and therapeutical uses thereof
06/02/2000CA2352665A1 Amino- and mercurio-substituted 4',5'-dihydropsoralens and therapeutical uses thereof
06/02/2000CA2350189A1 Recombinant methods and materials for producing epothilone and epothilone derivatives
05/2000
05/31/2000EP1003541A1 Inhibitors of hiv reverse transcriptase
05/31/2000CN1254715A Isoesperamicin and its synthesizing process and usage
05/30/2000CA2012826C Novel cyclic acetals
05/25/2000WO2000029375A1 Bisaryl compounds and cancer remedies containing the same
05/24/2000EP1001957A1 Macrolides with antitumor activity
05/24/2000EP1001951A1 Thiazole derivatives, method for their production and use
05/24/2000EP0931083A4 Process for producing ecteinascidin compounds
05/24/2000EP0815095B1 10-deacetylbaccatine iii and 10-deacetyl 14 beta-hydroxybaccatine iii derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
05/24/2000CN1254337A N-hydroxy 4-sulfonyl butyramide compounds
05/23/2000US6066642 For selectively blocking the a3 adenosine receptor of a mammal
05/23/2000US6066638 Fungicidal pyrimidinones
05/18/2000WO2000027839A1 Rameswaralide and rameswaralide derivatives
05/18/2000WO2000000514A3 Synthetic spiroketal pyranes as potent anti-cancer agents
05/17/2000EP1001036A2 Enzymatic processes for resolution of enantiomeric mixtures of compounds useful as intermediates in the preparation of taxanes
05/17/2000EP1000941A1 Diaminorhodamine derivatives
05/17/2000EP0869959B1 1,7-disubstituted perylene-3,4,9,10-tetracarboxylic acids and dianhydrides and diimides of said acids
05/17/2000EP0776202B1 Liposome-encapsulated taxol, its preparation and its use
05/17/2000CN1253559A Sulfonyl divalent aryl alpha-hydroxamic acid compounds
05/17/2000CN1253507A Acid-labile and enzymatically divisible dye structure for diagnosis with near infrared light and for therapy
05/17/2000CN1253474A Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds